Abstract
Osteoporosis patients are known to total 12,800,000 in Japan, a result of an increasing aged population. However, only 20-30% of them are appropriately treated. Now there are numerous osteoporosis drugs, which cause the confusion among doctors. This comprehensive review will summarize characteristics of each drug, and support the use of proper drugs for proper patients.